Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132911) titled 'A randomized, openlabel, controlled, multicenter phase III clinical trial of 7MW3711 versus docetaxel for locally advanced or metastatic squamous nonsmallcell lung cancer previously treated with platinumbased chemotherapy and immunotherapy' on Sept. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Chest Hospital
Condition:
Patients with locally advanced or metastatic squamous nonsmallcell lung cancer who have previously received platinumbased chemotherapy and immunotherapy
Intervention:
the docetaxel control arm:Docetaxel Injection
Recruitment Status: Not Recruiting ...